Investor · SOUTH SAN FRANCISCO, CA

James H. Evangelista

Open James in the network graph →

Filings

11

SEC Form D

Connections

71

co-filers

Capital

$209.8M

across filings

Active

Oct 2022

to Jan 2025

Most-connected co-filers (71)

Matthew P. Jacobson · SOUTH SAN FRANCISCO, CA9 shared Walter N. Moos · South San Francisco, CA9 shared Thilo H. Schroeder · SOUTH SAN FRANCISCO, CA9 shared David J. Earp · SOUTH SAN FRANCISCO, CA6 shared Stephen H. Kelsey · SOUTH SAN FRANCISCO, CA6 shared John Josey · SOUTH SAN FRANCISCO, CA4 shared Nicholas Schappler · Kansas City, MO3 shared David Strong · St. Louis, MO3 shared Michael Raynor · Tysons, VA3 shared Michael R. Farris · St. Louis, MO3 shared Bryan L. Burns · St. Louis, MO3 shared David L. Kearney · St. Louis, MO3 shared Travis Overton · Kansas City, MO3 shared R. Erick Hawkins · St. Louis, MO3 shared Paul H. Park · SOUTH SAN FRANCISCO, CA3 shared Randall J. Combs · St. Louis, MO3 shared Vibhu R. Sharma · Newport Beach, CA3 shared Eric C. Tremblay · VANCOUVER, British Columbia, Canada3 shared John L. Rice · St. Louis, MO3 shared Ronald N. Zazworsky, Jr · Atlanta, GA3 shared Peter Casella · Brooklyn, NY3 shared Cole G. Parks · Stephenville, TX3 shared Courtney J. Fortner · St. Louis, MO3 shared Kevin Hall · Kansas City, MO3 shared

Recent filings (11)

Troluce Veridian Onshore Fund, LPJul 2025 · 2 co-filers$12.8M Circle Pharma, Inc.Jan 2025 · 23 co-filers$117.4M Circle Pharma, Inc.Jan 2025 · 23 co-filers$117.4M Troluce Veridian Onshore Fund, LPSep 2024 · 2 co-filers Circle Pharma, Inc.Aug 2024 · 23 co-filers$117.4M Circle Pharma, Inc.Aug 2024 · 23 co-filers$117.4M Circle Pharma, Inc.Jul 2024 · 23 co-filers$117.4M Circle Pharma, Inc.Jul 2024 · 23 co-filers$117.4M Surround Care, LLCMay 2024 · 32 co-filers$155.0M Surround Care, LLCNov 2023 · 31 co-filers$15.0M Switch Therapeutics Inc.Nov 2022 · 14 co-filers$36.0M Surround Care, LLCNov 2022 · 32 co-filers$573.5M Switch Therapeutics Inc.Oct 2022 · 14 co-filers$35.0M Circle Pharma, Inc.Mar 2022 · 19 co-filers$66.3M Circle Pharma, Inc.Mar 2022 · 19 co-filers$66.3M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See James in the interactive graph →